# Fuhua Capital

> Fuhua Capital is a VC fund backing Biotechnology, Manufacturing and Battery. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 5
- Last investment: Jan 2025
- Lead investor: 20%
- Last updated: Aug 2026

Fuhua Capital is an investment firm.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 40% |
| Manufacturing | 2 | 40% |
| Battery | 1 | 20% |
| Medical | 1 | 20% |
| Enterprise | 1 | 20% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 60% |
| Seed | 1 | 20% |
| Angel | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Bit Intelligence | BitSmart is committed to solving the network scalability and communication efficiency problems faced by artificial intelligence. | $68.3M | Angel | Jan 06, 2025 |  |
| Liongo | Liongo develops innovative electrolyte materials to fulfil the needs of sophisticated batteries in a variety of application domains. | $14M | Series A | Jun 09, 2023 |  |
| PhaBuilder | PhaBuilder is a platform-based & product-based company with advanced technology in synthetic biology, focusing on the transformation and engineering application of halophilic microbes.PhaBuilder was founded in February 2021 by Professor Guoqiang Chen, director of the Center for Synthesis and Systems Biology at Tsinghua University. It mainlyuses the cutting-edge "Next Generation Industrial Biotechnology(NGIB)" to develop and produce a variety of high-value-added products such as PHA - a biodegradable material, ectoine - a pharmaceutical intermediate, and cadaverine - a Nylon 56 precursor. PhaBuilder currently has two PHA plants under construction - the synthetic biology intelligent development plant in Beijing China-Germany Industrial Park and the 10 kt/annum plant in Yichang, Hubei Province. It also plans to build up 3-5 large-scale production bases throughout China within five years. At present, PhaBuilder has completed two rounds of financing, raising around 300 million yuan in total. The investors include Sequoia Capital, China State-owned Enterprise Mixed Ownership Reform Fund, and GRC SinoGreen Fund, etc. In the future, PhaBuilder will constantly promote synthetic biotechnology to deeply integrate with people's lives and upgrade the intelligent biological manufacturing industry, in order to achieve PhaBuilder's core mission of "Using microbes to change the world and build a green future". | $53.3M | Series A | Feb 02, 2023 |  |
| PAM2L Biotechnologies | Boyin Bio is an innovative biomaterial research and development and application enterprise. | $14.8M | Seed | Jan 12, 2023 |  |
| Best Compound Semiconductor | Best Compound Semiconductor is a provider of professional epitaxial foundry services for the high-voltage and high-power application market. The company also provides SiC/SiC, GaN/Si Epitaxy Wafer Service for 4-inch and 6-inch silicon carbide, and 6-inch and 8-inch silicon-based GaN with high-quality manufacturing capabilities to meet newneeds.Best Compound Semiconductor was established in 2019 and is based in Nanjing, China. |  | Series A | Mar 07, 2022 |  |

5 of 5 investments shown.

## Co-investors
- [GRC SinoGreen Fund](https://shizune.co/investors/profile/grc-sinogreen-fund) — VC Fund, 3 deals together
- [Agricultural Fund of China](https://shizune.co/investors/profile/agricultural-fund-of-china) — VC Fund, 1 deal together
- [Anchen Technology (Yunnan) Co.](https://shizune.co/investors/profile/anchen-technology-yunnan-co) — VC Fund, 1 deal together
- [Chengtong Mixed Reform](https://shizune.co/investors/profile/chengtong-mixed-reform) — VC Fund, 1 deal together
- [China State-owned Enterprise Mixed Ownership Reform Fund](https://shizune.co/investors/profile/china-state-owned-enterprise-mixed-ownership-reform-fund) — VC Fund, 1 deal together
- [Co-Stone Venture Capital](https://shizune.co/investors/profile/co-stone-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Fuhua Capital invest in?

Fuhua Capital invests primarily in Biotechnology, Manufacturing and Battery startups, most often at Series A and Seed stage. Most of the 5 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Fuhua Capital last invest?

The most recent investment recorded for Fuhua Capital closed in Jan 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co